Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Industry Should Make Concerted Efforts to Make Generics More Reliable: Mr Kinoshita
February 2, 2009
- Pfizer to Acquire Wyeth
February 2, 2009
- Oncolys, Sysmex to Jointly Develop Diagnostic Agents for Cancer
February 2, 2009
- Industry Concerned about Obama Administration's Intervention in Drug Pricing
February 2, 2009
- FUJIFILM to Market Given Imaging's PillCam SB Endoscope
February 2, 2009
- Astellas Proposes Acquisition to CV Therapeutics
February 2, 2009
- JIRA to Demand Digital X-Ray Imaging Fee
February 2, 2009
- Financial Crisis Offers Opportunity for Cash-Rich Biopharma Companies: BCG
February 2, 2009
- MEDICAL DEVICE NEWS IN BRIEF
February 2, 2009
- Hisamitsu to Comarket Fosamac with Banyu
February 2, 2009
- SELF-MEDICATION NEWS IN BRIEF
February 2, 2009
- Wholesalers Have Been Driven Over the Edge: Mr Kimura
February 2, 2009
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 2, 2009
- BUSINESS NEWS IN BRIEF
February 2, 2009
- Takeda to Face Critical Test in Next 1-2 Years: Mr Hasegawa
February 2, 2009
- 4 New Drugs from Novartis Approved at the Same Time
February 2, 2009
- 79 Unapproved APIs Used in 32% of Med. Institutions
February 2, 2009
- Makers Should Provide Information to Enhance the Value of Their Products: Mr Kinoshita
February 2, 2009
- NHI Prices of Novoseven Re-Priced Upward due to Unprofitability
January 26, 2009
- Series of Tamiflu-Resistant Viruses Detected
January 26, 2009
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…